NM_000020.3:c.1232G>C
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000020.3(ACVRL1):c.1232G>C(p.Arg411Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R411Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000020.3 missense
Scores
Clinical Significance
Conservation
Publications
- telangiectasia, hereditary hemorrhagic, type 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
- hereditary hemorrhagic telangiectasiaInheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000020.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACVRL1 | NM_000020.3 | MANE Select | c.1232G>C | p.Arg411Pro | missense | Exon 8 of 10 | NP_000011.2 | ||
| ACVRL1 | NM_001077401.2 | c.1232G>C | p.Arg411Pro | missense | Exon 7 of 9 | NP_001070869.1 | |||
| ACVRL1 | NM_001406487.1 | c.1232G>C | p.Arg411Pro | missense | Exon 9 of 11 | NP_001393416.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACVRL1 | ENST00000388922.9 | TSL:1 MANE Select | c.1232G>C | p.Arg411Pro | missense | Exon 8 of 10 | ENSP00000373574.4 | ||
| ACVRL1 | ENST00000550683.5 | TSL:1 | c.1274G>C | p.Arg425Pro | missense | Exon 7 of 9 | ENSP00000447884.1 | ||
| ACVRL1 | ENST00000551576.6 | TSL:1 | c.1232G>C | p.Arg411Pro | missense | Exon 9 of 11 | ENSP00000455848.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 2 Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 411 of the ACVRL1 protein (p.Arg411Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with hereditary hemorrhagic telangiectasia (PMID: 15024723, 16123970, 17384219; Invitae). ClinVar contains an entry for this variant (Variation ID: 8257). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACVRL1 protein function. Experimental studies have shown that this missense change affects ACVRL1 function (PMID: 20501893). This variant disrupts the p.Arg411 amino acid residue in ACVRL1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8640225, 14684682, 15024723, 20414677, 23805858). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at